Exploring how molecular chaperones help break down protein aggregates linked to Alzheimer's disease.
Understanding the role of molecular chaperone systems in protein aggregate disassembly
This study is looking at how certain helpers in our cells can break down harmful protein clumps that are linked to Alzheimer's and other brain diseases, with the hope of finding new ways to treat these conditions.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Marquette University NIH-funded |
| Lab location | 1 site (Milwaukee, United States) |
| Project ID | NIH-10974631 on NIH RePORTER |
What this research studies
This research investigates the role of molecular chaperones in managing protein aggregates that are associated with neurodegenerative diseases like Alzheimer's. The team will study how these chaperones disassemble harmful protein structures, which can become irreversible with age and stress. By understanding the mechanisms behind this process, the research aims to uncover new therapeutic strategies for treating conditions related to protein aggregation. Patients may benefit from insights that could lead to innovative treatments for Alzheimer's and similar diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or related neurodegenerative disorders.
Not a fit: Patients with non-neurodegenerative conditions or those without protein aggregation-related diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that effectively treat or slow the progression of Alzheimer's disease.
How similar studies have performed: Other research has shown promise in understanding the role of molecular chaperones in protein aggregation, suggesting that this approach could yield significant advancements.
Where this research is happening
Milwaukee, United States
- Marquette University — Milwaukee, United States (Active)
Researchers
- Principal investigator: Manogaran, Anita L. — Marquette University
- Study coordinator: Manogaran, Anita L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.